Declines in stimulated striatal dopamine release over the first 32 h following microdialysis probe insertion: Generalization across releasing mechanisms

Brain Research

Volumn 808, Issue 2, 1998, Pages 182-189

  Holson, R Robert ^a   Gazzara, Russell A ^b   Gough, Bobby ^b  

^a NEW MEXICO INSTITUTE OF MINING AND TECHNOLOGY   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Axotomy; Bupropion; D OPAC; Dopamine; Haloperidol; Microdialysis; Potassium; Rat; Striatum; Time course

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AMFEBUTAMONE; DOPAMINE; HALOPERIDOL; METHAMPHETAMINE; POTASSIUM;

ANIMAL EXPERIMENT; ARTICLE; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; IMPLANTATION; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NERVE FIBER TRANSECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; AXOTOMY; BUPROPION; CORPUS STRIATUM; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; HALOPERIDOL; MALE; MICRODIALYSIS; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0032547881     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00816-6     Document Type: Article

References (24)

1. Akiyama Y., Koshimura K., Ohue T., Lee K., Miwa S., Yamagata S., Kikuchi H. Effects of hypoxia on the activity of the dopaminergic neuron system in the rat striatum as studied by in vivo brain microdialysis. J. Neurochem. 57:1991;997-1002.
2. Anden N.-E., Fuxe P.B., Ungerstedt U. Early and selective increase in brain dopamine levels after axotomy. Experientia. 28:1972;300-302.
3. Anden N.-E., Magnusson T., Stock G. Effects of drugs influencing monoamine mechanisms on the increase in brain dopamine produced by axotomy or treatment with gammahydroxybutyric acid. Naunyn-Schmiedeberg's Arch. Pharmacol. 278:1973;363-372.
4. Benveniste H., Huttemeier P.C. Microdialysis - theory and application. Prog. Neurobiol. 35:1990;195-215.
5. Bowyer J.F., Gough B., Slikker W. Jr., Lipe G.W., Newport G.D., Holson R.R. Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats. Pharmacol. Biochem. Behav. 44:1993;87-98.
6. Camp D.M., Robinson T. On the use of multiple probe insertions at the same site for repeated intracerebral microdialysis experiments in the nigrostriatal dopamine system of rats. J. Neurochem. 58:1992;1706-1715.
7. Carrozza D.P., Ferraro T.N., Golden G.T., Reyes P.F., Hare T.A. In vivo modulation of excitatory amino acid receptors: microdialysis studies on N-methyl-D-aspartate-evoked striatal dopamine release and effects of antagonists. Brain Res. 574:1992;42-48.
8. Commissiong J.W., Slimovitch C., Toffano G. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle. Br. J. Pharmacol. 99:1990;741-749.
9. Cooper B.R., Hester T.J., Maxwell R.A. Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo. J. Pharmacol. Exp. Ther. 215:1980;127-134.
10. Holson R.R., Bowyer J.F., Clausing P., Gough B. Methamphetamine-stimulated striatal dopamine release declines rapidly over time following microdialysis probe insertion. Brain Res. 739:1996;301-307.
11. Imperato A., Di Chiara G. Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis. J. Neurosci. 5:1985;297-306.
12. Kehr W. Temporal changes in catecholamine synthesis of rat forebrain structures after axotomy. J. Neural. Trans. 35:1974;307-317.
13. Keller H.H., Bartholini G., Pieri L., Pletscher A. Effects of spreading depression on the turnover of cerebral dopamine. Eur. J. Pharmacol. 20:1972;287-290.
14. R. Kuczenski, D.S. Segal, Neurochemistry of amphetamine, in: A.K. Cho, D.S. Segal (Eds.), Amphetamine and its Analogues, Academic Press, 1994, pp. 81-113.
15. Moghaddam B., Bunney B.S. Utilization of microdialysis for assessing the release of mesotelencephalic dopamine following clozapine and other antipsychotic drugs. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 14:1990;S51-S57.
16. Moghaddam B., Schenk J.O., Stewart W.B., Hansen A.J. Temporal relationship between neurotransmitter release and ion flux during spreading depression and anoxia. Can. J. Physiol. Pharmacol. 65:1987;1105-1110.
17. Obrenovitch T.P., Zilkha E., Urenjak J. Intracerebral microdialysis: electrophysiological evidence of a critical pitfall. J. Neurochem. 64:1995;1884-1887.
18. Reiriz J., Ambrosio S., Cobos A., Ballarin M., Tolosa E., Mahy N. Dopaminergic function in rat brain after oral administration of calcium-channel blockers or haloperidol. A microdialysis study. J. Neural Transm. Gen. Sect. 95:1994;195-207.
19. Robinson T.E., Camp D.M. The effects of four days of continuous striatal microdialysis on indices of dopamine and serotonin neurotransmission in rats. J. Neurosci. Methods. 40:1991;211-222.
20. Robinson T.E., Castaneda E., Whishaw I.Q. Compensatory changes in striatal dopamine neurons following recovery from injury induced by 6-OHDA or methamphetamine: a review of evidence from microdialysis studies. Can. J. Psychol. 44:1990;253-275.
21. Speckenbach W., Kehr W. Effect of (+)amphetamine on monoamine synthesis and metabolism after axotomy in rat forebrain. Naunyn-Schmiedeberg's Arch. Pharmacol. 296:1976;25-30.
22. Westerink B.H.C., De Vries J.B. characterization of in vivo dopamine release as determined by brain microdialysis after acute and subchronic implantations: methodological aspects. J. Neurochem. 51:1988;683-687.
23. Westerink B.H.C., Santiago M., De Vries J.B. The release of dopamine from nerve terminals and dendrites of nigrostriatal neurons induced by excitatory amino acids in the conscious rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 345:1992;523-529.
24. Westerink B.H.C., Tuinte M.H.J. Chronic use of intracerebral dialysis for the in vivo measurement of 3,4-dihydroxyphenylacetic acid. J. Neurochem. 46:1986;181-185.